News Center

Home page

Peak Report

News reports

Announcement on Resolution of the 11th Board of Directors

Release time:

2021-05-20

Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Pro 2020-032

Zhejiang Jianfeng Group Co., Ltd.

11th Session of Board Resolution Announcement

The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .

1. Board Meeting

(I) The convening and convening of this board meeting complies with relevant laws, regulations and the relevant provisions of the Articles of Association.

(II) 2020 11 April 12 , the company issued the notice of the board meeting by fax, e-mail and personal delivery.

(III) 2020 11 January 17 , this board meeting was held by a combination of on-site and communication voting.

(IV) company has nine directors, all of whom attended the meeting.

2. Board Meeting Deliberations

1 , Passed "Proposal on Election of Chairman"

After deliberation and voting, the Board of Directors passed "Proposal on Election of Chairman".

elected Mr. Jiang Xiaomeng as the chairman of the 11th board of directors of the company. The term of office is the same as that of the current board of directors. The resume is attached.

voting result: 9 votes in favor, 0 votes against, 0 votes abstaining.

2 , passed the "Proposal on Election of Special Committees of the Board of Directors"

After deliberation and voting, the board of directors passed the "Proposal on Election of Special Committees of the Board of Directors".

elected Mr. Jiang Xiaomeng, Mr. Yu Jianhong, Mr. Huang Sujian, Mr. Shen Weiguo and Mr. Yang Dalong as members of the Strategy Committee of the 11th Board of Directors, and Mr. Jiang Xiaomeng as the chairman.

elected Ms. Fu Qi, Mr. Shen Weiguo, and Mr. Jiang Xiaomeng as members of the Audit Committee of the 11th Board of Directors, and Ms. Fu Qi as the chairman.

elected Mr. Shen Weiguo, Mr. Yang Dalong and Mr. Jiang Xiaomeng as members of the nomination committee of the 11th board of directors, and Mr. Shen Weiguo as chairman.

elected Mr. Yang Dalong, Mr. Shen Weiguo and Mr. Jiang Xiaomeng as members of the Remuneration and Evaluation Committee of the 11th Board of Directors, and Mr. Yang Dalong as the chairman.

The term of office of the members of the above-mentioned special committees is the same as that of the current board of directors.

voting result: 9 votes in favor, 0 votes against, 0 votes abstaining.

3 , passed the "Proposal on Appointment of General Manager"

After deliberation and voting, the board of directors passed the "Proposal on Appointment of General Manager".

Mr. Yu Jianhong was appointed as the general manager of the company for the same term as the current board of directors. The resume is attached.

voting result: 9 votes in favor, 0 votes against, 0 votes abstaining.

4 , passed the "Proposal on Appointment of Deputy General Manager and Chief Financial Officer"

After deliberation and voting, the board of directors passed the "Proposal on Appointment of Deputy General Manager and Chief Financial Officer".

appointed Mr. Huang Jinlong, Mr. Zhang Fengliang and Mr. Xiang Chongping as deputy general managers of the company, and Mr. Lan Xiaolong as chief financial officer (chief financial officer) of the company. The term of office is the same as that of the current board of directors. The resume is attached.

voting results: 9 votes in favor, 0 votes against, 0 abstentions.

and passed the "Proposal on Appointment of Board Secretary and Securities Affairs Representative"

After deliberation and voting, the board of directors passed the "Proposal on Appointment of Board Secretary and Securities Affairs Representative".

appointed Mr. Zhu Jianwei as the secretary of the board of directors and Ms. Yu Guo as the representative of securities affairs. The term of office is the same as that of the current board of directors. The resume is attached.

voting results: 9 votes in favor, 0 votes against, 0

abstentions.

# Three independent directors of 128 company expressed their independent opinions on the above proposal. They believed that the educational background, work experience and professional quality of all the personnel appointed by the board of directors met the requirements of the post, There is no situation that the company's directors, supervisors and senior managers are not allowed to serve as the company's directors, supervisors and senior managers, and are determined by the CSRC to be banned from the market or have not been lifted.

3. Relevant Annex

1 , Resolution

of the 1st Meeting of the 11th Board of Directors of the Company, Independent Director Opinion

of the 11th Independent Director of the Company on the above Related Matters This is to announce

Zhejiang Jianfeng Group Co., Ltd.

Board of Directors

2020 november 18

Attached: resume

1 , Mr. Jiang Xiaomeng: 1964 September, master of business administration / engineering, professor-level senior engineer, licensed pharmacist, expert enjoying special allowance of the state Council, young and middle-aged expert with outstanding contribution from Zhejiang province, 1980

May to work, successively served as workshop director of Jinhua cement factory, manager of the company's enterprise management department, general manager of Zhejiang Jianfeng Communication Cable Co., Ltd., general manager of Zhejiang Jianfeng Pharmaceutical Co., Ltd., deputy general manager and general manager of the company. He is currently the Chairman and Secretary of the Party Committee of the Company, concurrently serving: vice Chairman of the Board of Directors of Tianshili Holding Group Co., Ltd., Vice Chairman of Tianshili Pharmaceutical Group Co., Ltd., Director of Southern Cement Co., Ltd., Chairman of Zhejiang Jinhua Nanfang Jianfeng Cement Co., Ltd., Director of Jinhua Tongji State-owned Assets Investment Co., Ltd., Zhejiang Building Materials Chairman of Industry Association, Vice President of Zhejiang Chamber of Commerce, Vice President of Zhejiang Entrepreneurs Association, Honorary President of Jinhua Entrepreneurs Association.

2 , Mr. Yu Jianhong: 1966 January, senior economist, engineer, EMBA , 1987

July to work, successively served as deputy director of Jinhua cement plant machine repair workshop, technical section chief, deputy director and director of Jinsong cement plant, general manager of Jianfeng group Jinhua Jinma cement co., ltd, general Manager of Zhejiang Jianfeng Cement Co., Ltd., Deputy General Manager of the Company, currently Director and General Manager of the Company, concurrently Vice President of Zhejiang Cement Association, Director of Tianshili Holding Group Co., Ltd. 3 , Mr. Huang Jinlong: born in 1965 2 March, master's degree, professor-level senior engineer and licensed pharmacist. 1988 July to work, served as Zhejiang otokang pharmaceutical co., ltd. quality inspection section chief, deputy factory director, Zhejiang otokang pharmaceutical group development manager; 1998

January joined the company successively as product development manager, general manager assistant, deputy general manager and executive deputy general manager of Zhejiang Jianfeng pharmaceutical co., ltd; he is currently a Director, Deputy General Manager and General Manager of Peak Pharmaceuticals of the Company. 4 , Mr. Zhang Fengliang: born in 1977 , October 19, graduate student, master of business administration, senior engineer. 1999

, he joined the work, successively served as the main operator of the kiln in the manufacturing workshop of Zhejiang Jianfeng Jinma Cement Co., Ltd., the director of the manufacturing workshop of Zhejiang Jianfeng Dengcheng Cement Co., Ltd., and the deputy general manager and executive deputy general manager of Daye Jianfeng Cement Co., Ltd.; he is currently the deputy general manager and general manager of Daye Jianfeng, vice chairman of daye city Federation of Industry and Commerce and Commerce and vice chairman of Hubei Cement Association. 5 , Mr. Xiang Chongping: born in 1964 10 , bachelor's degree, bachelor's degree, law degree, senior economist, enterprise legal consultant, human resources manager. 1981 November, served as deputy director of the office, vice chairman of the trade union, manager of the enterprise management department and director of the office of Jinhua enterprise building co., ltd. 1997

may, and served as deputy manager, manager, group office director and assistant to the general manager of the company's human resources department. He is currently the Deputy General Manager of the Company and the President of Jinhua Trademark Association. 6 , Mr. Lan Xiaolong: 1973 January birth, bachelor's degree, accountant. 1997

# September May to participate in the work, served as the company's financial staff, Jinhua City Pharmaceutical Company's financial manager, Zhejiang Jianfeng Pharmaceutical Co., Ltd. finance department deputy manager, manager, chief financial officer. He is currently the financial officer of the Company. 7 , Mr. Zhu Jianwei: 1967 , born in November , master of business administration, economist, 1991

8 May to work, successively served as the company's planning and development department, Shanghai office, securities management department, board of directors office staff, currently the company's board of directors secretary. 8 , Ms. Yu Guo: 1996 January birth, bachelor's degree.

2018

# joined the company in July

and may, and successively worked in the finance department of Zhejiang Jianfeng pharmaceutical co., ltd. and the office of the board of directors of the company.

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页